69 results
Page 2 of 4
8-K
EX-99.1
ihptlls7m1
12 May 23
Avenue Therapeutics Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
8:35am
424B3
jdv w23n3
4 May 23
Prospectus supplement
4:30pm
8-K
EX-99.1
hz3zff
17 Apr 23
Avenue Therapeutics Announces Regulatory Update Based on Type C Meeting with FDA and Next Steps in the Development of IV Tramadol
4:06pm
8-K
EX-99.1
9dzqmtv23mjlkk
30 Mar 23
Avenue Therapeutics Reports Full Year 2022 Financial Results and Recent Corporate Highlights
4:07pm
8-K
EX-99.1
g92d67in
10 Nov 22
Avenue Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
4:29pm
424B4
asfu2 yka0
11 Oct 22
Prospectus supplement with pricing info
8:27am
FWP
8pae2atxmrzs6
6 Oct 22
Free writing prospectus
4:05pm
8-K
EX-99.1
8mlgtlvcg
22 Sep 22
Material Modifications to Rights of Security Holders
4:32pm
8-K
k7trbqy1o rm
31 Aug 22
Other Events
5:23pm
8-K
EX-99.1
3mlr c6usek9pj
16 Feb 22
Avenue Therapeutics Announces Outcome of FDA Advisory Committee Meeting on IV Tramadol
7:39am